GE HealthCare Technologies Inc. (GEHC) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
GE HealthCare Technologies Inc. stock (GEHC) is currently trading at $72.20. GE HealthCare Technologies Inc. PE ratio is 15.60. GE HealthCare Technologies Inc. PS ratio (Price-to-Sales) is 1.57. Analyst consensus price target for GEHC is $93.47. WallStSmart rates GEHC as Hold.
- GEHC PE ratio analysis and historical PE chart
- GEHC PS ratio (Price-to-Sales) history and trend
- GEHC intrinsic value — DCF, Graham Number, EPV models
- GEHC stock price prediction 2025 2026 2027 2028 2029 2030
- GEHC fair value vs current price
- GEHC insider transactions and insider buying
- Is GEHC undervalued or overvalued?
- GE HealthCare Technologies Inc. financial analysis — revenue, earnings, cash flow
- GEHC Piotroski F-Score and Altman Z-Score
- GEHC analyst price target and Smart Rating
GE HealthCare Technologies Inc.
📊 No data available
Try selecting a different time range
GEHC Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · GE HealthCare Technologies Inc. (GEHC)
GEHC trades 156% above its Graham fair value of $30.94, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
GE HealthCare Technologies Inc. (GEHC) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in market cap, return on equity, price/sales. Concerns around eps growth. Fundamentals are solid but monitor weak areas for improvement.
GE HealthCare Technologies Inc. (GEHC) Key Strengths (4)
93.39% of shares held by major funds and institutions
Large-cap company with substantial market presence
Every $100 of equity generates $22 in profit
Paying $1.57 for every $1 of annual revenue
Supporting Valuation Data
GE HealthCare Technologies Inc. (GEHC) Areas to Watch (6)
Earnings declining -17.70%, profits shrinking
Premium pricing at 3.1x book value
Modest revenue growth at 7.10%
Growth is fairly priced, not cheap, not expensive
Decent operational efficiency, solid but not exceptional
Decent profitability, keeps $10 per $100 revenue
GE HealthCare Technologies Inc. (GEHC) Detailed Analysis Report
Overall Assessment
This company scores 60/100 in our Smart Analysis, earning a C+ grade. Out of 10 metrics analyzed, 4 register as strengths (avg 9.0/10) while 6 fall into concern territory (avg 4.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Institutional Own., Market Cap, Return on Equity. Valuation metrics including Price/Sales (1.57) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 22.40%.
The Bear Case
The primary concerns are EPS Growth, Price/Book, Revenue Growth. Some valuation metrics including PEG Ratio (1.70), Price/Book (3.15) suggest expensive pricing. Growth concerns include Revenue Growth at 7.10%, EPS Growth at -17.70%, which may limit upside. Profitability pressure is visible in Operating Margin at 15.70%, Profit Margin at 10.10%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 22.40% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 7.10% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Institutional Own., Market Cap) and negatives (EPS Growth, Price/Book). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
GEHC Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
GEHC's Price-to-Sales ratio of 1.57x sits near its historical average of 1.82x (7th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 27% below its historical high of 2.16x set in Sep 2024, and 5% above its historical low of 1.5x in Oct 2023. Over the past 12 months, the PS ratio has compressed from ~1.9x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for GE HealthCare Technologies Inc. (GEHC) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
GE HealthCare Technologies Inc. operates as a stable business with moderate growth and solid fundamentals. Revenue reached 20.6B with 7% growth year-over-year. Profit margins of 10.1% are healthy, with room for further expansion as the business scales.
Key Findings
ROE of 22.4% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 917M in free cash flow and 1.1B in operating cash flow. Earnings are translating into actual cash generation.
What to Watch Next
Margin expansion: can GE HealthCare Technologies Inc. push profit margins above 15% as the business scales?
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact GE HealthCare Technologies Inc..
Bottom Line
GE HealthCare Technologies Inc. offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 10:04:30 AM
About GE HealthCare Technologies Inc.(GEHC)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.